Yasuo Suzuki

MediBIC Group is a holding company which engages in the biotechnology industry that specializes in pharmacogenomics (PGx). It engages in analysis and reporting service on healthcare and drug development; information processing, services and consulting in biotech field; computer system design and development; drug & diagnostic product development; and business consulting services. The firm’s services also include sample banking and management service, GLP-compliant Gene Profiling Service, genetic testing service, licensing, cell culture systems and consumable sale. The company was founded on February 17, 2000 and is headquartered in Tokyo, Japan.